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Abstract
Background: Audit and feedback to physicians is a commonly used quality improvement strategy, but its optimal
design is unknown. This trial tested the effects of a theory-informed worksheet to facilitate goal setting and action
planning, appended to feedback reports on chronic disease management, compared to feedback reports provided
without these worksheets.
Methods: A two-arm pragmatic cluster randomized trial was conducted, with allocation at the level of primary care
clinics. Participants were family physicians who contributed data from their electronic medical records. The ‘usual
feedback’ arm received feedback every six months for two years regarding the proportion of their patients meeting
quality targets for diabetes and/or ischemic heart disease. The intervention arm received these same reports plus a
worksheet designed to facilitate goal setting and action plan development in response to the feedback reports.
Blood pressure (BP) and low-density lipoprotein cholesterol (LDL) values were compared after two years as the
primary outcomes. Process outcomes measured the proportion of guideline-recommended actions (e.g., testing and
prescribing) conducted within the appropriate timeframe. Intention-to-treat analysis was performed.
Results: Outcomes were similar across groups at baseline. Final analysis included 20 physicians from seven clinics
and 1,832 patients in the intervention arm (15% loss to follow up) and 29 physicians from seven clinics and 2,223
patients in the usual feedback arm (10% loss to follow up). Ten of 20 physicians completed the worksheet at least
once during the study. Mean BP was 128/72 in the feedback plus worksheet arm and 128/73 in the feedback alone
arm, while LDL was 2.1 and 2.0, respectively. Thus, no significant differences were observed across groups in the
primary outcomes, but mean haemoglobin A1c was lower in the feedback plus worksheet arm (7.2% versus 7.4%,
p<0.001). Improvements in both arms were noted over time for one-half of the process outcomes.
Discussion: Appending a theory-informed goal setting and action planning worksheet to an externally produced
audit and feedback intervention did not lead to improvements in patient outcomes. The results may be explained
in part by passive dissemination of the worksheet leading to inadequate engagement with the intervention.
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Background
Audit and feedback is often the foundation of quality
improvement (QI) projects aiming to close the gap be-
tween ideal and actual practice. Audit and feedback is
known to improve quality of care but there is variability
in the magnitude of effect observed [1]. This variability
may be attributed to the nature of the targeted behavior,
the context, and the characteristics of the recipient, as
well as to the design of the audit and feedback interven-
tion itself [2]. The Cochrane review of audit and feed-
back found that feedback is more effective when sent
more than once, delivered by a supervisor or senior col-
league in both verbal and written formats, and when it
includes both explicit targets and an action plan [3].
However, these conclusions are based on indirect com-
parisons from meta-regressions and are thus less reliable
than those that would be generated directly from head-
to-head trials of different approaches to providing audit
and feedback. Further, there is little information to guide
operationalization of these factors [4]. For example, few
audit and feedback trials explicitly describe goal setting
or action planning as part of the intervention, and those
trials that did appeared to deliver this component of the
intervention in various ways [5,6]. Although action plan-
ning is a familiar activity in clinical practice, the plan can
more effectively lead to behavior change if it includes two
key elements: an ‘if ’ statement (specifying contextual fac-
tors that will trigger the action) and a ‘then’ statement
(specifying precisely the action to be taken) [7]. In the
context of feedback and goals, implementation intention-
based action plans could increase goal-directed behaviors
possibly by increasing both self-efficacy (confidence in
ones ability to perform an action effectively) and goal-
commitment (degree to which the person is determined to
achieve the goal) [8].
For patients with diabetes, audit and feedback is
known to modestly improve processes of care, as well
as blood pressure (BP) and glycemic control [9,10]. In
this trial, we aimed to build on the extant knowledge
regarding audit and feedback by asking not whether it
can improve care, but whether it could be modified to
be more effective to improve processes of care related
to patients with chronic disease, including diabetes and
ischemic heart disease (IHD). Our hypothesis was that
feedback reports delivered to family physicians regard-
ing care patterns for patients with chronic disease
would draw attention to a discrepancy between actual
and desired quality of care (e.g., fewer patients than
expected with BP recently measured) and that a work-
sheet accompanying the feedback to facilitate goal-setting
and action-planning would increase the likelihood that
family physicians would act to improve quality of care
(e.g., identify and more aggressively treat patients with
BP above target).
Methods
Study design
This was a two-arm, pragmatic cluster-trial conducted
in primary care. To reduce the risk of contamination,
randomization was at the level of the primary care clinic.
Each physician in the intervention clinics received feedback
accompanied by a goal-setting and action-planning work-
sheet, while each physician in the clinics allocated to usual
care received feedback unaccompanied by the worksheet.
Feedback reports addressed guideline-based quality indica-
tors for patients in their practice with diabetes and/or IHD.
Such patients are at elevated risk of cardiovascular events,
especially if they have a history of both conditions [11], and
guidelines recommend similar processes of care as well as
control of BP and cholesterol to reduce this risk [12,13].
The trial was pragmatic in that it sought to determine if the
intervention could be effective under usual circumstances:
the goal-setting and action-planning worksheet was de-
signed to be readily scalable and was delivered with
minimal supports; the usual feedback arm was not stan-
dardized with respect to co-interventions; patient-level out-
comes were assessed from databases with unobtrusive
measurement of compliance; and analysis was by intention-
to-treat [14]. The protocol has been previously published
[15] and is summarized below. This study received approval
from the Research Ethics Office at Sunnybrook Health
Sciences Centre (271–2006) and registered at Clinical-
Trials.gov (NCT00996645).
Setting
In the province of Ontario, patients with chronic condi-
tions such as diabetes and stable ischemic heart disease
are generally managed in primary care, mostly by family
physicians. There is no co-pay for doctor visits or labora-
tory tests for Ontarians, but medications are covered by
the provincial drug plan only for the elderly and those on
social assistance. The majority of primary care providers
in the province work in groups and are paid by a mix of
capitation and fee for service.
Participants and data collection
Participants were family physicians throughout Ontario
who signed data-sharing agreements with the Electronic
Medical Record Administrative data Linked Database
(EMRALD), held at the Institute for Clinical Evaluative
Sciences (ICES). EMRALD has developed mechanisms to
extract, securely transfer, and de-identify the electronic
medical record (EMR) data for analysis at ICES, maintain-
ing strict standards for confidentiality [16]. Family physi-
cians were originally invited to participate in EMRALD
through convenience sampling of EMR users and all
EMRALD contributors consented to this study. Physicians
with less than one year of experience using their EMR or
with less than 100 active adult patients enrolled in their
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practice were excluded. Included patients were over age 18
at the start of the trial, were enrolled with their family
physician throughout the study, and had diabetes and/or
IHD. Only patients with one or more visits at least one
year prior to the trial to were included to ensure that
enough data existed in the EMR to assess quality of care
and to ensure that providers were not audited for transient
or new patients. EMRALD has validated algorithms to
identify patients with diabetes and IHD, which do not re-
quire special data input by physicians [17,18].
Allocation
Practices were allocated using minimization (conducted by
the study analyst using the free software, MINIM [19]) to
achieve balance on baseline values of the primary outcomes
and on the number of eligible patients in each cluster [3].
Using the baseline data for each cluster, these variables
were classified as high or low using the median value as the
cut-point. After recruitment was completed, practices were
allocated simultaneously to ensure low risk of bias related
to allocation concealment, as per Cochrane Effective Prac-
tice and Organization of Care Group criteria [20].
Intervention
The intervention was developed through an iterative
process and piloted with family physicians, as described
previously [15]. Each physician received a package (Table 1)
by courier every six months for two years featuring feed-
back reports describing the aggregate percentage of pa-
tients with diabetes and/or IHD meeting quality targets,
along with explanatory documents and self-reflection sur-
veys to be completed for continuing medical education
credits (CME). For each disease condition, the report fit on
one page and for every quality target, the aggregate per-
formance achieved by the participating physician was com-
pared to the score achieved by the top 10% of participating
physician performers [21]. See Additional file 1 for proto-
type feedback reports. The frequency was limited to twice
yearly for two years due to capacity of the research team,
and the reports included only aggregate data (no patient-
specific information) due to potential privacy risks of send-
ing patient-specific information.
Physicians randomized to the feedback plus worksheet
arm also received a one-page worksheet appended to the
feedback along with the standard CME survey. The work-
sheet was designed to facilitate goal-setting and imple-
mentation intention-based action-plans, using the ‘if ’ and
‘then’ formulation explained above [8]. See Additional file
2 for prototype of worksheet. Participants were asked to
submit the worksheet along with the CME surveys in
order to process their CME credits.
Prior to the second cycle of feedback reports, the College
of Family Physicians of Canada implemented the use of
standardized forms to earn continuing medical education
credits for practice audits. Therefore, the CME surveys
changed during the trial. The original surveys asked partic-
ipants what they learned about diabetes and IHD care,
intention to change practice, and asked about potential
barriers to change. The revised surveys asked participants
to ‘make a decision about your practice,’ to declare ‘what
will you have to do to integrate these decisions,’ and to con-
tinue to reassess the practice change and make further
plans to improve. Given the nature of the intervention,
blinding of physicians was not possible, but they were not
aware of the exact nature of the intervention being tested.
Outcomes
Outcomes were monitored using validated processes to
analyze data collected from participants’ EMRs. There
were two patient/disease-level primary outcomes and one
professional practice/process-level primary outcome. The
patient-level primary outcomes were the patients’ most re-
cent low-density lipoprotein cholesterol (LDL) and systolic
BP values, if tested within 24 or 12 months, respectively.
The process-level primary outcome was a composite
process score indicating whether patients received pre-
scriptions and tests in accordance with relevant guidelines
[22-27]. Patients received a composite process score with
a maximum of six, as outlined in Table 2 which we multi-
plied by 100 to report the score as a percentage.
Secondary outcomes were chosen because they were
thought to reflect the targets of action by family physicians
receiving the feedback. Each of the items in the composite
process score was assessed, plus glycemic control (haemo-
globin A1c level, HbA1c), the proportion meeting targets
recommended in guidelines for LDL (<2 mmol/L), and BP
(<130/80 mmHg in diabetes and <140/90 mmHg in IHD),
and prescriptions rates for insulin and beta blockers.
Table 1 Intervention components and description
Feedback reports One page focusing on patients with diabetes and one on patients with heart disease. Aggregate rather than
patient-specific data provided. Performance compared to top 10% of peers, presented in tables and bar graphs.
Explanatory document One page description of how data was generated, including possible limitations.
Suggestions document One page with clinical recommendations (ie. managing muscle aches for patients taking statins)
and generic quality improvement strategies (i.e.. work with administrative staff to encourage
patients to have periodic visits only for chronic disease management)
Continuing medical education form Two-page self-reflection survey required by the College of Family Physicians
to earn continuing medical education credits related to practice audits.
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While not every patient requires each prescription or in-
vestigation, we anticipated balance between groups in the
proportion of eligible patients. Therefore, increases in ag-
gregate proportions of processes performed indicate gen-
eral intensification of treatment for patients with these
conditions.
Analysis
Primary analysis was performed on an intention-to-treat
basis, using patient level variables, combining patients
with diabetes and/or IHD. Because the intervention was
directed to the physician, final analysis was limited to
patients with diabetes and/or IHD who were enrolled in
their physician’s practice throughout the trial. We used
linear mixed models (SAS MIXED procedure) for con-
tinuous variables to estimate the mean difference in each
outcome between arms, together with their 95% confi-
dence interval (CI). For dichotomous variables, we used
generalized estimating equation models (SAS GENMOD
procedure) and estimated relative risk and the 95% con-
fidence interval using log-binomial regression [28]. We
used generalized linear models to examine random vari-
ation for each outcome at both physician and practice
levels (SAS GLIMMIX procedure). The clustering of pa-
tients within physicians was accounted for using random
effect models and if the practice-level was also significant
we included both levels when assessing outcomes. We ran
a model for each outcome with and without adjustment
for baseline values of the dependent variable. The adjust-
ment for baseline values of the dependent variable was
carried out by specifying the pre-intervention measure of
the outcome as a covariate. We planned this approach a
priori because although there were thousands of patients,
we were not confident that allocation of only 14 clinics
would result in adequate balance at baseline [3,29].
Planned sub-group analyses were performed on patients
with only IHD, only diabetes, or both, to assess the same
outcome variables. We hypothesized that patients with
only IHD would have lower quality of care scores at
baseline and greater potential for improvement during the
intervention because locally it has received relatively less
attention with respect to QI initiatives and because identi-
fying patients in the EMR with IHD is more difficult than
identifying patients with DM due to the lack of relevant la-
boratory results or specific medications. A planned per-
protocol analysis assessed whether full completion of the
intervention worksheet resulted in improved outcomes in
general and for the specific clinical topics in participants’
goal statements. All analyses were carried out using the
SAS Version 9.2 statistical program (SAS Institute, Cary,
NC, USA).
The number of participating practices and eligible physi-
cians providing data to EMRALD determined the sample
size. With 54 physicians from 14 practices initially provid-
ing data and consenting to this trial and a presumed intra-
cluster correlation of 0.05, we estimated 80% power to find
an absolute difference in LDL of 0.32 mmol/L and in sys-
tolic BP of 7 mmHg, based on pilot data [15].
Results
Cluster and patient flow are described in Figure 1. Just
prior to allocation, one physician stopped practicing. Thus,
the study began with 4,617 patients cared for by 53 physi-
cians from 14 clinics. At baseline (August 2010), 22 physi-
cians cared for 2,157 patients with diabetes and/or IHD in
the feedback plus worksheet arm and 31 physicians cared
for 2,460 patients were in the usual feedback arm. During
the two-year trial two physicians from each arm were lost
to follow up. Of the 562 patients lost to follow up, 175
belonged to these four physicians, and 166 changed physi-
cians during the study. Average age of patients lost to fol-
low up was 68 years and 44% were female, reflecting the
underlying distribution of those allocated.
Comparability at baseline
Cluster and participant characteristics are described in
Table 3 and Table 4, respectively. The median number of
included patients per clinic was 234, (interquartile range
Table 2 Composite process score calculated for each patient as primary process outcome
Quality indicator
(for each patient receives a score)
Diabetes
(maximum score = 6)
IHD
(maximum score = 6)
Both diabetes + IHD
(multiply by 6/7 for max score = 6)
BP test in 6 M X X X
A1C test in 6 M X X
FBG test in 24 M X
LDL test in 12 M X X X
ACR test in 12 M X X
Rx ASA X X
Rx Statin X X X
Rx ACE/ARB X X X
IHD ischemic heart disease, BP blood pressure, A1C haemoglobin A1c, FBG fasting blood glucose, LDL low density lipoprotein cholesterol, ACR urinary
albumin-to-creatinine ratio, ASA aspirin, ACE/ARB angiotensin-modifying agent.
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(IQR) 186 – 508) and the median per physician was 81
(IQR, 46 – 111). One-half of the practices (7/14, 50%) were
located in urban settings. About one-half of the physicians
were female (25/53, 47%). Physicians had been in practice
for a median of 19 years (IQR, 9 – 24) and had been using
their EMR for a median of 7 years (IQR 6 – 7). Intervention
physicians were more likely to be male, with more years ex-
perience, and located in rural settings. They also tended to
have smaller practices overall but with more eligible pa-
tients. Patients averaged 65.6 years and 44.4% were female.
Most included patients (3,435, 74.4%) had diabetes, the re-
mainder had IHD (25.6%); one-eighth (12.4%) had both dia-
betes and IHD. The mean weight of included patients was
89 kilograms (standard deviation [SD] = 26, 501 missing).
Mean BP was 130/74 (systolic SD = 17, diastolic SD = 11,
467 missing), with 55.1% achieving target, and mean LDL
was 2.31 (SD = 0.9, 674 missing), with 67.7% achieving tar-
get. The mean process composite score was 72 (SD = 26).
Values for these variables and other process measures were
similar across groups, except for greater proportion of pa-
tients in the feedback plus worksheet arm group than the
feedback alone arm with a recent BP test (85% versus 74%)
and HbA1c test (79% versus 69%).
Intention-to-treat analyses
There were 4055 patients cared for by 49 physicians
from 14 clinics in the final analysis. The primary and
secondary outcomes at the end of the trial are summa-
rized in Table 5. No clinically or statistically significant
differences were observed across groups in the primary
outcomes in both the adjusted and unadjusted models.
Mean systolic BP was 128 in both arms (adjusted mean
14 clinics and
53 physicians
Allocated to intervention
(feedback + worksheet)
7 clinics
22 physicians
2157 patients
Allocated to usual care
(feedback alone)
7 clinics
31 physicians
2460 patients
Analyzed
7 clinics
20 physicians
1832 patients
Analyzed
7 clinics
29 physicians
2223 patients
Lost to follow up
0 clinics
2 physicians
(1 withdrew, 1 retired)
237 patients
Lost to follow up
0 clinics
2 physicians 
(1 died, 1 retired)
325 patients
Figure 1 Cluster-Patient flow diagram.
Table 3 Baseline characteristics of clinics, and family
physicians
Feedback plus
worksheet
Feedback
alone
Clinic characteristics (N = 14) 7 7
Total patients (median, IQR) 3,121 (2,258 – 2,671) 4,432 (3,488 – 8,201)
Eligible* patients (median, IQR) 205 (189 – 389) 257 (211 – 499)
Location (n, % rural) 4 (57%) 2 (29%)
Physician characteristics
(N = 53)
22 31
Roster size (median, IQR) 1,010 (596 – 1,416) 1,291 (884 – 1,696)
Sex (n, % female) 6 (27%) 19 (61%)
Years in practice (median, IQR) 23 (16 – 25) 15 (7 – 22)
Years using EMR (median, IQR) 7 (6.7 – 7.9) 6 (6.2 – 6.6)
Eligible* patients (median, IQR) 77 (49 – 120) 179 (62 – 216)
*Eligible patients are those meeting inclusion criteria with diabetes and/or
heart disease.
IQR = interquartile range, % = proportion.
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difference = −0.05; 95% CI −2.11, 2.02) and diastolic BP
was 72 in the feedback plus worksheet arm and 73 in the
feedback alone arm (adjusted mean difference = −0.72; 95%
CI −2.18, 0.75). LDL was 2.1 in the feedback plus work-
sheet arm and 2.0 in the feedback alone arm (adjusted
mean difference = 0.04; 95% CI −0.02, 0.10). The mean
composite score was 72 in the feedback plus worksheet
arm and 70 in the feedback alone arm [adjusted mean dif-
ference = 1.76; 95% CI −1.4, 4.9]. Mean HbA1c in patients
with diabetes was lower in the feedback plus worksheet
arm (7.2% versus 7.4%; adjusted mean difference −0.2; 95%
CI −0.3, -0.1). A greater proportion of patients in the feed-
back plus worksheet arm had their BP tested within six
months (81% versus 69%, adjusted relative risk [aRR] = 1.2;
95% CI 1.1, 1.3) and more achieved target BP (53% versus
46%, aRR 1.2; 95% CI 1.0 – 1.3). No other outcomes were
significantly different across the arms.
After adjusting for variation at the level of the physi-
cians, there was no further significant variation at the level
of the clinic so that all models included a random variable
only for the physician. Patients with no recent values for
BP or LDL did not differ across arms with respect to sex,
or proportion with diabetes and/or IHD. Those with miss-
ing values for BP were also similar with respect to age, but
patients with missing values for LDL from the feedback
plus worksheet arm tended to be older than those in the
feedback alone arm (68 years versus 63 years; p = 0.001).
LDL values and diastolic BP decreased slightly in both
study arms over time, while systolic BP decreased only
in the feedback plus worksheet arm (Additional file 3:
Table S6). HbA1c also decreased in the feedback plus
worksheet arm, but increased slightly in the feedback only
arm. The proportion of patients with BP and LDL at target
increased in both arms during the study period. The pro-
portion with an LDL test within 12 months and the pro-
portion with a statin prescribed also improved over time
in both arms, but the proportion with BP measured within
6 months decreased in both arms and the proportion pre-
scribed an anti-hypertensive (beta blocker or angiotensin-
modifying agent) did not change over time except for a
small increase in angiotensin-modifying agents in the
feedback alone arm. Insulin prescribing increased in both
arms over time, but testing of HbA1c and fasting blood
glucose decreased.
Results of the planned sub-group analyses for patients
with only diabetes, only IHD, or both conditions are de-
scribed in Additional file 3: Table S7, Table S8, Table S9.
The results indicate that patients with IHD are treated
more aggressively than patients with only diabetes and
that patients with both conditions are treated most aggres-
sively. Mean BP and LDL values were lowest and the com-
posite process score was highest among patients with
diabetes and IHD.
Per-protocol analyses
One-half of physicians in the intervention arm completed
the worksheet (10/22, 45%); of those, one-half responded
only once. Restricting analysis for the primary outcomes to
the 10 physicians who completed the intervention work-
sheet indicated non-statistically significant improvement in
the feedback plus worksheet arm for systolic BP (126 ver-
sus 128, adjusted mean difference −0.8; 95% CI −3.1, 1.5)
and for the composite score (73 versus 70, adjusted mean
difference 2.6; 95% CI −2.0, 7.2), but a slight decrease in
LDL (2.1 versus 2.0, adjusted mean difference 0.1; 95% CI
0.0, 0.2). The most common goals set by participants in the
worksheet for their patients with diabetes were for achieve-
ment of target BP (i.e., increase the proportion of patients
meeting BP target, three times) and increasing testing rates
Table 4 Baseline characteristics of patients
Feedback plus
worksheet
Feedback
alone
ICC
Patients (total = 4,617) 2,157 2,460 -
IHD only 545 (25%) 637 (26%) -
DM only 1,329 (62%) 1,534 (62%) -
IHD and DM 283 (13%) 289 (12%) -
Age (mean years ± sd) 67 ±14 65 ±14 -
Female 906 (42%) 1,251 (46%) -
WT (mean kg ± sd) 88 ±22 90 ±29 0.047
Systolic BP (mean mmHg ± sd) 130 ±18 129 ±17 0.058
Diastolic BP (mean mmHg ± sd) 73 ±11 75 ±11 0.079
LDL (mean mmol/l ± sd) 2.3 ±0.9 2.3 ±0.9 0.053
HbA1c^ (mean% ± sd) 7.4 ±1.4 7.3 ±1.4 0.011
LDL at target~ 665 (31%) 826 (34%) 0.051
BP at target~ 1,019 (47%) 1,054 (43%) 0.071
BP test in 6 M 1,839 (85%) 1,831 (74%) 0.183
A1C test in 6 M^ 1,267 (79%) 1,250 (69%) 0.079
FBG test in 24 M 1,904 (88%) 2,134 (87%) 0.091
LDL test in 12 M 1,574 (73%) 1,770 (72%) 0.096
ACR test in 12 M^ 1,044 (65%) 1,232 (68%) 0.195
Rx ASA* 602 (73%) 657 (71%) 0.092
Rx Statin 1,463 (68%) 1,757 (71%) 0.051
Rx ACE/ARB^ 1,153 (71%) 1,243 (68%) 0.068
Rx Beta blocker* 497 (60%) 562 (61%) 0.008
Rx insulin^ 339 (21%) 391 (21%) 0.006
Composite process score
(mean ± sd)
73 ±25 71 ±27 0.106
Legend: ICC = Intra-cluster correlation reported at physician-level, ^ = Calculated
for patients with diabetes, * Calculated for patients with IHD, ~ = Target BP
130/80 for diabetes but 140/90 for IHD and Target LDL < 2, IHD = ischemic heart
disease, BP = blood pressure, A1C = haemoglobin A1c, FBG = fasting blood
glucose, LDL = low density lipoprotein cholesterol, ACR = urinary albumin-to-
creatinine ratio, ASA = aspirin, ACE/ARB = angiotensin-modifying agent, kg =
kilogram, sd = standard deviation.
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of urinary albumin-to-creatinine ratio (three times). The
most common goals for IHD were for achievement of tar-
get LDL (three times) and increasing prescription rates of
ASA (five times). Patients belonging to the 10 participants
who completed the worksheets more often achieved BP
targets but the effect was not statistically significant (52%
versus 46%, aRR = 1.11; 95% CI 0.97, 1.27). Testing for
urinary albumin was similar between arms (66% versus
65%, aRR = 1.00; 95% CI 0.86, 1.17), as was achievement of
LDL targets (48% versus 50%, aRR = 0.99; 95% CI 0.90,
1.09). Prescribing rates of ASA was higher among partici-
pants who completed the worksheets, but the model-based
difference was not statistically significant, as baseline rates
of ASA prescribing were also higher in this group (67%
versus 57%, aRR = 0.99; 95% CI 0.95, 1.04).
Discussion
We found no difference in the primary outcomes of BP
and cholesterol levels and no difference in the composite
process score when providers were given feedback plus a
goal-setting and action-planning worksheet compared to
feedback alone. While it was a secondary outcome and
should be interpreted cautiously, the intervention did
result in improved glycemic control to a similar extent as
many other complex QI strategies for diabetes [30]. We
also observed that BP and cholesterol improved in both
arms, as well as one-half of the process outcomes, which
emphasizes the importance of controlled studies when
testing strategies aiming to improve quality of care.
It remains plausible that completing a goal-setting and
action-planning exercise could enhance the effectiveness
of feedback [1]. Unfortunately, only 10 out of 22 physi-
cians in the intervention arm completed the intervention
worksheet and only five of these completed it more than
once. Poor compliance (with minimal supports) limited
our ability to test the effects of action planning in this
pragmatic trial. One-half of the goals set by active partici-
pants were behavioral (what will I do) and one-half were
outcome-oriented (what would I like to happen as the re-
sult of what I do). For actions plans to be most effective,
they must very specifically relate to behavioral goals, not
outcome goals [31]. Thus, it would seem that one-half of
participants who completed the worksheet did so ineffect-
ively, and there is a need to explore how to make action-
planning activities more salient and usable. More active,
practice-based supports may be needed to implement the
Table 5 Outcomes for patients receiving feedback plus the goal-setting and action-planning worksheet versus
feedback alone
Feedback + worksheet Feedback alone Model-based differences in quality of care outcomes
N = 1,832 N = 2,223
Continuous outcomes MD 95% CI Missing Adjusted MD 95% CI Missing
Systolic BP 128 ±18 128 ±16 0.35 −2.24, 2.95 554 −0.05 −2.11, 2.02 743
Diastolic BP 72 ±11 73 ±11 −1.48 −3.34, 0.38 554 −0.72 −2.18, 0.75 743
LDL 2.1 ±0.8 2.0 ±0.8 0.04 −0.06, 0.14 643 0.04 −0.02, 0.10 927
HbA1c%^ 7.2 ±1.3 7.4 ±1.5 −0.24 −0.38, -0.09 572 −0.20 −0.33, -0.06 794
Composite score 72 ±26 70 ±28 4.85 −0.52, 10.21 0 1.76 −1.37, 4.89 0
Dichotomous outcomes RR 95% CI Adjusted RR 95% CI
LDL at target 866 (47%) 1,119 (50%) 0.97 0.85, 1.13 0.97 0.90, 1.06
BP at target 965 (53%) 1,023 (46%) 1.21 1.05, 1.40 1.15 1.02, 1.29
BP test in 6 M 1,491 (81%) 1,541 (69%) 1.25 1.11, 1.42 1.16 1.06, 1.26
A1C test in 6 M^ 947 (71%) 1,067 (65%) 1.12 0.98, 1.28 1.07 0.95, 1.21
FBG test in 24 M 1,596 (87%) 1,918 (86%) 1.03 0.97, 1.10 1.03 0.98, 1.08
LDL test in 12 M 1,217 (66%) 1,480 (67%) 1.03 0.93, 1.16 1.02 0.93, 1.12
ACR test in 12 M^ 851 (64%) 1,060 (65%) 1.02 0.87, 1.20 1.05 0.93, 1.20
Rx ASA* 552 (75%) 615 (73%) 1.03 0.95, 1.11 0.99 0.96, 1.03
Rx statin 1,309 (72%) 1,686 (76%) 0.96 0.89, 1.03 0.97 0.94, 1.00
Rx ACE/ARB^ 647 (83%) 679 (84%) 1.05 0.97, 1.14 0.98 0.95, 1.00
Rx beta blocker* 440 (59%) 514 (61%) 1.00 0.90, 1.10 0.99 0.95, 1.03
Rx insulin^ 351 (26%) 426 (26%) 0.99 0.85, 1.16 1.01 0.99, 1.04
All models adjusted for clustering. Adjusted models also controlled for baseline values of dependent variable.
Legend: ^Analysis restricted to patients with diabetes, *Analysis restricted to patients with IHD, ~ Target BP 130/80 for diabetes and 140/90 for IHD and
Target LDL<2.
MD mean difference, RR relative risk, IHD ischemic heart disease, BP blood pressure, A1C haemoglobin A1c, FBG fasting blood glucose, LDL low density lipoprotein
cholesterol, ACR albumin-to-creatinine ratio, ASA aspirin, ACE/ARB angiotensin-modifying agent, Rx active prescription, CI confidence interval, M months.
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development of goals and action plans. For instance, one
randomized control trial found that feedback reports plus
structured peer interactions in which goals and action plans
for improvement were discussed was more effective than
feedback alone [32]. A recent Canadian cross-sectional
study showed that data management support for patient
identification and recall plus assistance by allied health pro-
viders with standardized testing and prescribing was associ-
ated with improved quality in primary care [33].
To result in behavior change, those receiving feedback
must be dissatisfied with their performance, meet a thresh-
old level of self-efficacy for improvement, and be commit-
ted to the goal [7,34]. In our separately reported embedded
qualitative evaluation [35], we found that self-efficacy was
low, as many practices lacked the necessary QI infrastruc-
ture to take action. For example, no one was responsible
for searching the EMR to identify patients who may re-
quire reassessment. Our qualitative work also found that
participants were not highly committed to achieving the
targets described in the feedback reports. There was uncer-
tainty regarding the impact on patient outcomes of achiev-
ing targets perceived to be aggressive. Many expressed
concern that practice-level QI efforts would be at odds
with their attempts to achieve patient-centered care. It
would appear that although Canadian family physicians
generally agree with and accept guideline-based best-
practice targets for diabetes and IHD [36], achievement of
best-practice targets for chronic disease management was
not perceived as urgent compared to other tasks, especially
given the relatively high quality of care already achieved.
Yet, even if mean performance was acceptable, many pa-
tients stand to benefit from improved processes of care. In
such settings, to increase goal commitment it may be ne-
cessary to first address limited self-efficacy by providing
more active supports for QI [37], as there is evidence that
self-efficacy influences goal commitment [34]. Recognizing
that feedback alone is sometimes not enough to change
provider behaviors, further improvements have been
sought by pairing feedback with intensive co-interventions,
such as academic detailing [38] or practice facilitation [39].
In the Cochrane review, pairing educational outreach with
audit and feedback was found to increase desired profes-
sional behavior [3]. However, these intensive interventions
are costly and more cost-efficient approaches may exist.
The particular nature of the feedback intervention used
in this study may have played an important role in the
poor uptake of the intervention worksheet. Qualitative
work conducted in the Veterans Affairs health system in
the USA also indicates that high performing healthcare or-
ganizations tend to deliver feedback with more actionable
information [40]. It is possible that the participants did
not feel that achieving higher scores on their feedback was
achievable because only aggregate data was provided [41].
It is also possible that concerns regarding data validity
allowed participants to resolve any cognitive dissonance
arising from the results provided in the feedback without
needing to commit resources to improvement [42]. For in-
stance, the explanatory notes accompanying the reports
described that if relevant tests were conducted by special-
ists but were not received into the EMR in a standardized
format they would not be included in the feedback. In
addition, the presence of multiple competing priorities is
known to mitigate achievement of particular guideline rec-
ommendations [43], and this may be highly appropriate
for patients with significant symptoms from concomitant
illness (e.g., severe depression, cancer) or reduced life ex-
pectancy. The Cochrane review indicated that feedback
was less effective when targeting many indicators reflect-
ing chronic disease management than when targeting a
specific behavior, and feedback intervention theory sug-
gests that feedback should direct attention to a specific
task in order to most reliably change behavior [44]. It has
also been observed that feedback may be more effective
when participants choose standards [5], and when pre-
sented by senior colleagues [3], whereas externally gener-
ated feedback focusing on a multitude of guideline-based
best practices were used in this study. Therefore, the feed-
back may have been more salient—and the intervention
worksheet may have had greater impact—if it focused on
quality indicators chosen by participants to be high priority,
and delivered by carefully selected opinion leaders [45] with
clear and readily achievable tasks for improved scores.
Some limitations in this study warrant further discussion.
The lack of a pure control group limits our ability to com-
ment on the impact of this particular audit and feedback
intervention on quality of care. However, our approach
was necessary because participants expected something in
return for contributing data. Furthermore, feedback is
known to work for these outcomes [10] such that our
interest was in determining whether a simple enhancement
could increase feedback effectiveness. Although we used
minimization to achieve baseline balance successfully for
the primary outcomes, differences in cluster-level charac-
teristics remained. In addition, the study analyst had access
to the allocation list; this non-blinding could theoretically
create bias, but the same validated algorithms were used to
assess outcomes for each study group. We also acknow-
ledge the potential for measurement bias as investigations
were counted only if results were available in the EMR and
tests performed by specialists may be missed. For out-
comes related to investigations and treatments, data in
EMRALD compare well with (and often out-perform) ad-
ministrative databases [46]. While the trial should balance
reasons for misclassification or missing data, we observed
that those without a recent LDL test tended to be older in
the intervention arm. We took a pragmatic approach to
intervention delivery, limiting the number of reminders and
supports to mimic expected conditions if the intervention
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were to be widely implemented. This may explain the lim-
ited completion rate of the worksheet and raises a question
about the role of pragmatic health services trials when
evaluating ‘new’ interventions. In this case, more data re-
garding how to support implementation would have been
useful prior to embarking on a trial with this type of design.
We did embed a qualitative evaluation to explore this, but
participants focused on the usefulness of the particular
audit and feedback intervention used in this trial rather
than the goal-setting and action-planning worksheets [35].
It is also important to note that the secondary, per-protocol
analyses are at risk of bias in favour of the intervention.
In addition, a number of factors may have limited our
ability in this study to find differences between interven-
tion arms. First, while this study did include thousands of
patients, they were clustered within only 14 clinics and the
intra-cluster correlations for disease-level primary out-
comes were larger than expected from pilot data. Second,
physicians voluntarily provide data to EMRALD and many
participating clinics were involved in other QI interven-
tions. Thus, these clinics may be more innovative and may
also be achieving a higher level of evidence-based care
than most other primary care providers, potentially de-
creasing both generalizability and the likelihood of finding
an effect in this study. Furthermore, we observed that the
composite process score was highest among patients with
both diabetes and IHD indicating that participating pro-
viders appropriately intensified monitoring and manage-
ment in patients at greatest risk and suggesting the
possibility that further gains may be limited by a ceiling ef-
fect. Third, risk for type 2 error is exacerbated in trials
comparing similar interventions (i.e., head-to-head trials)
where anticipated effect sizes are not expected to be large.
Finally, differences between groups may also have been
more difficult to identify if goal-setting and action-
planning aspects of the intervention were duplicated by
the revised CME surveys mandated by the College of Fam-
ily Physicians. During the trial, 52% of physicians (14/27)
in the usual feedback group and 54% (12/22) in the feed-
back plus worksheet arm completed and returned at least
one CME survey. Unlike the first iteration of CME sur-
veys, which asked participants ‘what have you learned,’ the
revised surveys explicitly asked participants to make a de-
cision about their practice and to identify how to integrate
the decision into practice. Though less specific or directive
than the intervention worksheets, these questions may
have similarly prompted participants to set goals and de-
velop action plans.
In conclusion, we found no effect of adding a theory-
informed goal-setting and action-planning worksheet to
an audit and feedback intervention. Unfortunately, passive
dissemination of this worksheet led to inadequate engage-
ment with the intervention. In the context of primary care
practices with minimal QI infrastructure, CME credit
alone may not be enough incentive to encourage engage-
ment in goal-setting or action planning activities. To
maximize the impact of audit and feedback and to ensure
that QI in primary care is prioritized, relevant stake-
holders, including professional colleges, associations, and
health system payers, should consider the need for further
supports to carry out practice-based QI.
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